Standard Chemical & Pharmaceutical Co. Ltd. (1720) Stock Statistics & Valuation Metrics

Standard Chemical & Pharmaceutical Co. Ltd. has a market cap or net worth of TWD 10.81B. The enterprise value is TWD 14.30B.

Market Cap

TWD 10.81B

Enterprise Value

TWD 14.30B

Standard Chemical & Pharmaceutical Co. Ltd. has 196,565,700 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding

196,565,700

Owned by Insiders

―

Owned by Institutions

0.29%

Standard Chemical & Pharmaceutical Co. Ltd.’s return on equity (ROE) is 0.15 and return on invested capital (ROIC) is 10.70%.

Return on Equity (ROE)

0.15

Return on Assets (ROA)

0.08

Return on Invested Capital (ROIC)

10.70%

Return on Capital Employed (ROCE)

0.14

Revenue Per Employee

6.22M

Profits Per Employee

820.94K

Employee Count

1,130

Asset Turnover

0.60

Inventory Turnover

2.62

The current PE Ratio of Standard Chemical & Pharmaceutical Co. Ltd. is 10.22. Standard Chemical & Pharmaceutical Co. Ltd.’s PEG ratio is 0.52.

PE Ratio

10.22

PS Ratio

1.53

PB Ratio

2.96

Price to FCF

9.61

Price to Operating Cash Flow

11.58

PEG Ratio

0.52

In the last 12 months, Standard Chemical & Pharmaceutical Co. Ltd. had revenue of 7.02B and earned 927.66M in profits. Earnings per share was 5.19.

Revenue

7.02B

Gross Profit

2.91B

Operating Income

1.36B

Pretax Income

1.51B

Net Income

927.66M

EBITDA

1.80B

Earnings Per Share (EPS)

5.19

In the last 12 months, operating cash flow was 1.58B and capital expenditures -456.69M, giving a free cash flow of 1.12B billion.

Operating Cash Flow

1.58B

Free Cash Flow

1.12B

Free Cash Flow per Share

3.38

Standard Chemical & Pharmaceutical Co. Ltd. pays an annual dividend of ―, resulting in a dividend yield of 3.64%

Dividend Per Share

―

Dividend Yield

3.64%

Payout Ratio

N/A

Free Cash Flow Yield

10.40%

Earnings Yield

5.61%

Beta

0.11

52-Week Price Change

1.17%

50-Day Moving Average

56.46

200-Day Moving Average

55.64

Relative Strength Index (RSI)

33.68

Average Volume (3m)

222.42K

Standard Chemical & Pharmaceutical Co. Ltd. upcoming earnings date is Mar 02, 2027, TBA (Not Confirmed).

Last Earnings Date

Nov 06, 2026

Next Earnings Date

Mar 02, 2027

Ex-Dividend Date

―

Standard Chemical & Pharmaceutical Co. Ltd. as a current ratio of 2.53, with Debt / Equity ratio of 18.43%

Current Ratio

2.53

Quick Ratio

1.80

Debt to Market Cap

0.07

Net Debt to EBITDA

-0.39

Interest Coverage Ratio

161.32

In the past 12 months, Standard Chemical & Pharmaceutical Co. Ltd. has paid 258.35M in taxes.

Income Tax

258.35M

Effective Tax Rate

0.17

Standard Chemical & Pharmaceutical Co. Ltd. EV to EBITDA ratio is 5.14, with an EV/FCF ratio of 8.75.

EV to Sales

1.39

EV to EBITDA

5.14

EV to Free Cash Flow

8.75

EV to Operating Cash Flow

6.22

Standard Chemical & Pharmaceutical Co. Ltd. has TWD 2.32B in cash and marketable securities with TWD 1.04B in debt, giving a net cash position of TWD 1.29B billion.

Cash & Marketable Securities

TWD 2.32B

Total Debt

TWD 1.04B

Net Cash

TWD 1.29B

Net Cash Per Share

TWD 6.54

Tangible Book Value Per Share

TWD 27.40

Gross margin is 42.60%, with operating margin of 20.52%, and net profit margin of 14.51%.

Gross Margin

42.60%

Operating Margin

20.52%

Pretax Margin

23.87%

Net Profit Margin

14.51%

EBITDA Margin

27.05%

EBIT Margin

20.84%

The average price target for Standard Chemical & Pharmaceutical Co. Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―

Price Target

―

Price Target Upside

―

Analyst Consensus

―

Analyst Count

―

Revenue Growth Forecast

4.62%

EPS Growth Forecast

9.56%